评论——从透明度到问责制：寻找使专家建议值得信赖的方法。
Commentary - From Transparency to Accountability: Finding Ways to Make Expert Advice Trustworthy.
机构信息
Assistant Professor, Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON.
出版信息
Healthc Policy. 2022 Feb;17(3):28-33. doi: 10.12927/hcpol.2022.26731.
Abstract
Declining public trust in government and expert advice is a public health priority, given its impact on vaccination uptake, adherence to guidelines and social cohesion. In the context of the COVID-19 Vaccine Task Force, conflicts of interest that can threaten public trust are handled primarily through disclosures. However, this places the onus on the public to discern the relevance, severity and impact of these conflicts and does little to address whose interests guide decision making. Alternatively, expert advisory committees should adopt more trustworthy strategies, including promoting independence from commercial and political interests.
摘要
公众对政府和专家建议的信任度下降是一个公共卫生重点，因为这会影响疫苗接种率、对指导方针的遵守情况和社会凝聚力。在 COVID-19 疫苗工作队的背景下，可能威胁公众信任的利益冲突主要通过披露来处理。然而，这需要公众自己去辨别这些冲突的相关性、严重程度和影响，而对于解决谁的利益指导决策几乎没有什么作用。或者，专家咨询委员会应该采取更值得信赖的策略，包括促进不受商业和政治利益的影响。
相似文献
1
Commentary - From Transparency to Accountability: Finding Ways to Make Expert Advice Trustworthy.评论——从透明度到问责制：寻找使专家建议值得信赖的方法。
Healthc Policy. 2022 Feb;17(3):28-33. doi: 10.12927/hcpol.2022.26731.
2
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region.披露、透明和问责制：世界卫生组织东南亚区域公立部门药物委员会利益冲突政策的定性调查。
Global Health. 2022 Mar 18;18(1):33. doi: 10.1186/s12992-022-00822-8.
3
Conflicts of interest and the (in)dependence of experts advising government on immunization policies.利益冲突与为政府免疫政策提供咨询的专家的（不）独立性。
Vaccine. 2018 Nov 26;36(49):7439-7444. doi: 10.1016/j.vaccine.2018.10.058. Epub 2018 Oct 22.
4
COVID-19 Vaccine Task Force and Conflicts of Interest.COVID-19 疫苗工作组与利益冲突。
Healthc Policy. 2022 Feb;17(3):20-27. doi: 10.12927/hcpol.2022.26732.
5
Conflicts of Interest in Clinical Guidelines: Update of U.S. Preventive Services Task Force Policies and Procedures.临床指南中的利益冲突：美国预防服务工作组政策和程序的更新。
Am J Prev Med. 2018 Jan;54(1S1):S70-S80. doi: 10.1016/j.amepre.2017.06.034.
6
Insinuation Anxiety: Concern That Advice Rejection Will Signal Distrust After Conflict of Interest Disclosures.暗示性焦虑：在披露利益冲突后，担心拒绝建议会暗示不信任。
Pers Soc Psychol Bull. 2019 Jul;45(7):1099-1112. doi: 10.1177/0146167218805991. Epub 2018 Nov 17.
7
Food for thought? Potential conflicts of interest in academic experts advising government and charities on dietary policies.引人深思？学术专家在为政府和慈善机构提供饮食政策建议时可能存在的利益冲突。
BMC Public Health. 2016 Aug 5;16:735. doi: 10.1186/s12889-016-3393-2.
8
Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators.披露临床研究中的利益冲突：机构审查委员会、利益冲突委员会及研究者的观点
J Law Med Ethics. 2006 Fall;34(3):581-91, 481. doi: 10.1111/j.1748-720x.2006.00072.x.
9
Observational study of financial and non-financial conflicts of interest among the Japanese government advisory board members concerning coronavirus disease 2019.关于日本政府顾问委员会成员在 2019 年冠状病毒病方面的财务和非财务利益冲突的观察性研究。
Medicine (Baltimore). 2023 Jan 27;102(4):e32776. doi: 10.1097/MD.0000000000032776.
10
Is 'conflict of interest' a Misnomer? Managing interests in immunization research and evaluation.“利益冲突”是一个用词不当的说法吗？管理免疫研究和评估中的利益。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1879580. doi: 10.1080/21645515.2021.1879580. Epub 2021 Mar 2.
引用本文的文献
1
Addressing conflicts of interest regarding the vaccine in infectious disease outbreaks based on good governance for health approach: a policy brief.基于健康治理方法应对传染病疫情中疫苗的利益冲突：政策简报。
BMC Health Serv Res. 2023 Sep 25;23(1):1028. doi: 10.1186/s12913-023-10020-w.
2
Mobilization of science advice by the Canadian federal government to support the COVID-19 pandemic response.加拿大联邦政府为支持新冠疫情应对而调动科学建议。
Humanit Soc Sci Commun. 2023;10(1):19. doi: 10.1057/s41599-023-01501-8. Epub 2023 Jan 17.
3
Health Services and Policy Research in Canada: An Editor's Reflections.加拿大卫生服务与政策研究：编辑的反思。
Healthc Policy. 2022 Feb;17(3):6-14. doi: 10.12927/hcpol.2022.26735.
本文引用的文献
1
COVID-19 Vaccine Task Force and Conflicts of Interest.COVID-19 疫苗工作组与利益冲突。
Healthc Policy. 2022 Feb;17(3):20-27. doi: 10.12927/hcpol.2022.26732.
2
Trust in scientists in times of pandemic: Panel evidence from 12 countries.大流行时期对科学家的信任：来自 12 个国家的小组证据。
Proc Natl Acad Sci U S A. 2021 Oct 5;118(40). doi: 10.1073/pnas.2108576118.
3
A Politics of Objectivity: Biomedicine's Attempts to Grapple with "non-financial" Conflicts of Interest.客观性的政治：生物医学应对“非财务”利益冲突的尝试。
Sci Eng Ethics. 2021 Jun 7;27(3):37. doi: 10.1007/s11948-021-00315-8.
4
A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysis.对各健康相关研究机构管理“财务”和“非财务”利益的政策规定进行比较：定性内容分析。
Account Res. 2020 May;27(4):212-237. doi: 10.1080/08989621.2020.1748015. Epub 2020 Apr 9.
5
Improving researchers' conflict of interest declarations.改善研究人员的利益冲突声明。
BMJ. 2020 Mar 11;368:m422. doi: 10.1136/bmj.m422.
6
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries.欧洲的阳光政策与阴暗面：九个欧洲国家向卫生专业人员披露制药业付款情况。
Int J Health Policy Manag. 2018 Jun 1;7(6):504-509. doi: 10.15171/ijhpm.2018.20.
7
Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia.解码披露：比较美国、法国和澳大利亚的利益冲突政策。
Health Policy. 2018 May;122(5):509-518. doi: 10.1016/j.healthpol.2018.03.015. Epub 2018 Mar 21.
8
The unintended consequences of conflict of interest disclosure.利益冲突披露的意外后果。
JAMA. 2012 Feb 15;307(7):669-70. doi: 10.1001/jama.2012.154.
Zotero 插件